Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083809 · ClinicalTrials.gov registry record · NA
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02083809 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 166 participants.
The verdict
NCT02083809, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hypothesis, investigators will perform a randomized, double-blinded, placebo-controlled trial. The patient will be followed until discharged from the postoperative care unit during which time patient satisfaction, pain score and postoperative bleeding will be assessed.
Interventions
- DRUG intravenous oxytocin
- DRUG Intravenous Fluids and Electrolytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02083809
The ClinicalTrials.gov registry entry for NCT02083809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which intravenous oxytocin is the first listed.
NCT02083809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02083809 about?
NCT02083809 is a clinical study titled "Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation". Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hy...
What is the current status of trial NCT02083809?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2014-10. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02083809?
The interventions under investigation include: intravenous oxytocin (DRUG), Intravenous Fluids and Electrolytes (DRUG).
Who is sponsoring clinical trial NCT02083809?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.